VIRI

Virios Therapeutics, Inc.

0.21 USD
-0.02 (-6.86%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Virios Therapeutics, Inc. stock is down -54.44% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 May’s closed higher than April.

About Virios Therapeutics, Inc.

Virios Therapeutics, Inc. focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.